1. World Organization for Animal Health OIEWorld Organization for Animal Health / Office International des Epizooties 2015- Update on highly pathogenic avian influenza in animals (type H5 and H7)
  2. United States Department of Agriculture Animal and Plant Health Inspection Service USDA -Avian Influenza  
  3. UK Department for Environment, Food and Rural Affairs (DEFRA) Animal & Plant Health Agency Veterinary & Science Policy Advice Team - International Disease Monitoring / Updated Outbreak Assessment / Outbreaks of avian influenza in poultry in North America, Africa and Europe / 12th May 2015 Ref: VITT/1200 HPAI in North America, Africa & Europe.
  4. Abdelwhab, E. M., C. Grund, M. M. Aly, M. Beer, T. C. Harder, and H. M. Hafez. Influence of maternal immunity on vaccine efficacy and susceptibility of one day old chicks against Egyptian highly pathogenic avian influenza H5N1. Vet Microbiol 155:13-20. 2012.
  5. Bennejean G, M. Guittet, J.P. Picault, J.F. Bouquet, B. Devaux, D. Gaudry and Y. Moreau. Vaccination of one day-old chicks against Newcastle disease using inactivated oil adjuvant vaccine and/or live vaccine. Av. Pathol. 7, 15-27, 1978.
  6. Bonfante, F., Y. Gardin, C. Terregino, V. Berton, M. Giasuddin, B. C. Das, M. Yamage, V. Palya and I. Capua. Efficacy of a single dose rHVT-H5 avian influenza vector vaccine against a clade of H5N1 highly pathogenic virus. 18th World Veterinary Poultry Association WVPA Congress. Nantes, France, 2013. Download  PDF
  7. Ceva Animal Health. Registration dossier of Vectormune AIAvian Influenza. Experiment D. Perez. U. of Maryland. 2012.
  8. De Vriese, J., Y. Gardin, V. Palya, K. Moore Dorsey, B. Lambrecht, S. Van Borm, and T. van den Berg. Efficacy of a rHVT-AI vector vaccine in broilers, with passive immunity to HVTHerpes Virus of Turkey and AIVAvian Influenza Virus, against challenge with H5N1 HPAIV.16th World Veterinary Poultry Association WVPA Congress, Marrakesh, 2009 . Download  PDF
  9. De Vriese, J., M. Steensels, V. Palya, Y. Gardin, K. Moore-Dorsey, B. Lambrecht, S. Van Borm, and T. van den Berg. Passive protection afforded by maternally-derived antibodies in chickens and the antibodies’ interference with the protection elicited by avian influenza-inactivated vaccines in progeny.  Avian Dis. 54:246–252. 2010 .  
  10. Ip H. S., M.K. Torchetti, R. Crespo, P. Kohrs, P. DeBruyn, K. G. Mansfield, T. Baszler, L. Badcoe, B. Bodenstein, V. Shearn-Bochsler, M. L. Killian, J. C. Pedersen, N. Hines, T. Gidlewski, T. De Liberto, and J.M. Sleeman Novel Eurasian Highly Pathogenic Avian Influenza A H5 Viruses in Wild Birds. Emerging Infectious Diseases, Volume 21, Number 5, May 2015.
  11. Kapczynski D. R., M. Moraes, M. W. Jackwood and K. Moore Dorsey. Vaccination of SPF turkeys with a recombinant HVT expressing the HAHemagglutinin from H5N1 Highly Pathogenic avian Influenza protects against lethal challenge. AAAP meeting, San Diego, CA, USA. 2012. Download   PDF
  12. Kapczynski, D. R., M. Esaki, K. M. Dorsey, H. Jiang, M. Jackwood, M. Moraes, and Y. Gardin. Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza virus. Vaccine 33:1197-1205. 2015.
  13. Kilany, W. H., E. M. Abdelwhab, A. S. Arafa, A. Selim, M. Safwat, A. A. Nawar, A. M. Erfan, M. K. Hassan, M. M. Aly, and H. M. Hafez. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus. Vet Microbiol 150:28-34. 2011.
  14. Kilany W. H., M. Khalifa Hassan, S. Abd Elaziz, A. Abou El Fetou, Y. Gardin, V. Palya and M. Mehrez Aly. Evaluating the efficacy of recombinant HVT-H5 vaccine in commercial broiler chickens carrying Maternally Derived Antibody (MDAMaternally Derived Antibodies: antibodies produced by the breeders and transmitted to their progeny through the egg yolk.) to AI under field condition in Egypt. 8th International Symposium on Avian Influenza, London, UK. 2012. Download  PDF
  15. Kilany, W. H., G. Dauphin, A. Selim, A. Tripodi, M. Samy, H. Sobhy, S. VonDobschuetz, M. Safwat, M. Saad, A. Erfan, M. Hassan, J. Lubroth, and Y. Jobre. Protection conferred by recombinant turkey herpesvirus avian influenza (rHVT-H5) vaccine in the rearing period in two commercial layer chicken breeds in Egypt.  Avian Pathol 43: 514-523. 2014. Download  PDF  
  16. Lambrecht, B., M. Steensels, S. Van Borm, G. Meulemans, and T. van den Berg. Development of a M2e-specific ELISA for DIVA testing. Avian Dis. 51:221-226. 2007 .
  17. Palya, V., E. Kovács, T. Tatár-Kis, Z. G. Homonnay, T. Mató, T. Sato, and Y. Gardin. Replication of HVT AI (HA) vector vaccine in different species of waterfowl. 9th International Symposium on Avian Influenza, Athens, GA, USA. 2015. Download  PDF
  18. Peyre M., M.Choisy, H. Sobhy, W.H. Kilany, A. Tripodi, G. Dauphin, M. Saad, F. Roger, J.Lubroth, and Y. Jobre. Modeling Avian Influenza Immunity Distribution Profile Through the Poultry Production Network in Egypt: A Decision Tool for Zoonotic Influenza Management. 9th International Symposium on Avian Influenza, Athens, GA, USA. 2015. Download   PDF
  19. Rauw, F., V. Palya, S. Van Borm, S. Welby, T. Tatar-Kis, Y. Gardin, K. M. Dorsey, M. M. Aly, M. K. Hassan, M. A. Soliman, B. Lambrecht, and T. van den Berg. Further evidence of antigenic drift and protective efficacy afforded by a recombinant HVT-H5 vaccine against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Vaccine 29(14): 2590-2600. 2011.
  20. Rauw, F., S. Anbari, T. van den Berg, and B. Lambrecht. Measurement of systemic and local respiratory cell-mediated immunity after influenza infection in chickens. Vet Immunol Immunopathol 143:27-37. 2011.
  21. Rauw, F., V. Palya, T. Tatar-Kis, K. M. Dorsey, T. van den Berg, B. Lambrecht and Y. Gardin. Lack of interference between two recombinant HVT vaccines expressing the H5 protein of Avian Influenza or the F protein of Newcastle Disease administered simultaneously to day-old chicks and efficacy against challenges performed at 4 or 8 weeks of age. 8th International Symposium on Avian Influenza, London, UK. 2012. Download  PDF
  22. Rauw, F., V. Palya, Y. Gardin, T. Tatar-Kis, K. Moore-Dorsey, B. Lambrecht, and T. van den Berg. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains. Avian Dis 56: 913-922. 2012.
  23. Soejoedono R. D., S. Murtini, V. Palya, B. Felföldi, T. Mató and Y. Gardin Efficacy of a Recombinant HVT-H5 Vaccine Against Challenge with Two Genetically Divergent Indonesian HPAI H5N1 Strains. Download PDF . Avian Dis. 56:923–927. 2012.
  24. Steensels, M., B. Lambrecht, T. Harder, M. Beer, F. Rauw, Th. van den Berg, S. Marché, Y. Gardin, and V. Palya. Efficacy of a rHVT-H5 vaccine against the European HP H5N8 AIV strain isolated at the end of 2014. 9th International Symposium on Avian Influenza, Athens, GA, USA. 2015. Download  PDF   Avian Dis.60:202-209, 2016
  25. Swayne D. E., E. Spackman and M. Pantin Jackwood. Success factors for avian influenza vaccine use in poultry and potential impact at the wild bird-agricultural interface Download PDF .  Ecohealth. 11(1): 94-108. 2014.
  26. Walid H. Kilany, Mohammed K. Hassan, Marwa Safwat, Sami Mohammed,Abdullah Selim, Sophie VonDobschuetz, Gwenaelle Dauphin, Juan Lubroth & Yilma Jobre .Comparison of the effectiveness of rHVT-H5, inactivated H5 and rHVT-H5 with inactivated H5 prime/boost vaccination regimes in commercial broiler chickens carrying MDAs against HPAI H5N1 clade 2.2.1 virus, Avian Pathology, 2015 44:5, 333-341 ( )